1.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: DFCI-75100
|
|
2.
|
Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: MSKCC-75104
|
|
3.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and under Sponsor: NCI Protocol IDs: POG-7621
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: SEG-340
|
|
5.
|
Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-7406, MDAR-117
|
|
6.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-774/775
|
|
7.
|
Phase: Phase III Type: Treatment Status: Completed Age: over 18 Sponsor: Protocol IDs: WCG-130
|
|
8.
|
Phase: Phase III Type: Treatment Status: Closed Age: under 61 Sponsor: Protocol IDs: WCG-135
|
|
9.
|
Phase: Phase III Type: Treatment Status: Completed Age: under 18 Sponsor: NCI Protocol IDs: CCG-541, CLB-7691, POG-7660
|
|
10.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDAR-37
|
|
11.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-RT-8001
|
|
12.
|
Phase: Phase III Type: Treatment Status: Completed Age: 1 to 21 Sponsor: NCI Protocol IDs: POG-7909
|
|
13.
|
Phase: Phase III Type: Treatment Status: Completed Age: under 65 Sponsor: Protocol IDs: NCI-78-C-34, NCI-MB-93
|
|
14.
|
Phase: Phase III Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: CLB-8251, CALGB-8251
|
|
15.
|
Phase: Phase III Type: Treatment Status: Closed Age: 14 and over Sponsor: NCI Protocol IDs: BRMP-8904, UMCC-7824, NCI-79-C-143, NCI-MB-133, NCI-MB-ROB-133, NCI-T83-1467N, T83-1467
|
|
16.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: BRMP-8903, NCI-78-C-145, NCI-MB-110, NCI-N82-522, N82-0522
|
|
17.
|
Phase: Phase III Type: Treatment Status: Completed Age: 15 and over Sponsor: NCI Protocol IDs: NCI-81-C-166A, NCI-MB-161, NCI-T84-0248N, T84-0248
|
|
18.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: BRMP-8914, NCI-81-C-178, NCI-MB-166, NCI-T83-0977N, T83-0977
|
|
19.
|
Phase: Phase III Type: Treatment Status: Completed Age: 15 and over Sponsor: Protocol IDs: NCI-78-C-118, UMCC-7808, NCI-MB-114, NCI-T83-0983, T83-0983
|
|
20.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: YALE-HIC-1636, NCI-T83-1405D
|
|
21.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: UCCRC-2121B, NCI-V83-0124
|
|
22.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: MDA-IM-8007, NCI-V86-0049
|
|
23.
|
Phase: Phase III Type: Treatment Status: Closed Age: 15 to 60 Sponsor: Protocol IDs: EORTC-20822
|
|
24.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: UCCRC-3954, NCI-V84-0038
|
|
25.
|
Phase: Phase III Type: Treatment Status: Closed Age: any age Sponsor: NCI Protocol IDs: YALE-HIC-3281, NCI-T85-0116D, T85-0116
|